IRMD stock news · iRadimed Corporation
Get alerts for IRMD
Follow iRadimed Corporation (IRMD) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for IRMDFree on the App Store and Google Play, or on the web.
iRadimed cut its full-year forecast because of production problems, even though demand for its 3870 infusion pump is high.
Good or bad for IRMD?iRadimed Q3 2026 Earnings Call Transcript
Good for IRMDiRadimed reported record Q3 sales, higher profit per share, and a growing pump backlog. Rising production and expected Q4 growth make the update positive for the company.
IRADIMED CORP shared its financial results for the quarter that ended on September 30, 2026.
NeutralThis IRADIMED filing points to quarterly results, but the supplied text gives no sales or profit figures. It does not change the outlook for IRMD.
iRadimed Corporation will talk about its third quarter 2026 financial results on a call set for October 30, 2026.
NeutraliRadimed scheduled its third-quarter results report and a call, but shared no results yet. This notice does not change what we know about its business.